Growth medium and use thereof, and method for cultivating umbilical cord mesenchymal stem cells
A growth medium and basal medium technology, applied in animal cells, vertebrate cells, bone/connective tissue cells, etc., can solve problems such as poor expansion ability, and achieve the effect of improving expansion ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0029] Wherein, the preparation method of the growth medium of the present invention may include: mixing the basal medium with the additive.
[0030] The present invention also provides the use of the above-mentioned growth medium in culturing umbilical cord mesenchymal stem cells.
[0031] The present invention also provides a method for culturing umbilical cord mesenchymal stem cells, the method comprising: inoculating umbilical cord mesenchymal stem cells in the above-mentioned growth medium for culturing.
[0032] Among them, the culture temperature and CO 2The concentration can be a conventional choice in the field of umbilical cord mesenchymal stem cells; for example, the temperature of culture can be 36-38°C; the cultured CO 2 The concentration may be 4-6% by volume.
[0033] Wherein, the above-mentioned growth medium of the present invention can promote the rapid expansion of umbilical cord mesenchymal stem cells, correspondingly shortening the subculture period, so ...
preparation Embodiment 1
[0038] Fetal bovine serum (purchased from Gibco), bevacizumab (purchased from Roche), cetuximab (purchased from Merck), koji Tocilizumab (purchased from Roche) and guanosine-5-triphosphate trisodium salt (purchased from Sigma, hereinafter the same); the amount added makes the final concentration: fetal bovine serum 10% by volume, bevacizumab 0.08 ng / mL, cetuximab 0.06ng / mL, trastuzumab 0.15ng / mL and guanosine-5-triphosphate trisodium salt 1ng / mL; the growth medium of this preparation example was obtained.
preparation Embodiment 2
[0040] Fetal bovine serum (purchased from Gibco), bevacizumab (purchased from Roche), cetuximab (purchased from Merck), koji Tocilizumab (purchased from Roche) and guanosine-5-triphosphate trisodium salt; the amount added makes the final concentration: fetal bovine serum 10 volume%, bevacizumab 0.01ng / mL, cetuximab Antibody 0.1 ng / mL, trastuzumab 0.05 ng / mL and guanosine-5-triphosphate trisodium salt 300 μg / mL; the growth medium of this preparation example was obtained.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com